MARY SPANGLER: Open Payments
NPI 1275959256 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 13 payments from 9 companies in 2025. Trend: 2023 $206 · 2024 $96 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $96 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Boston Scientific Corporation | 1 | $34 |
| Seqirus USA Inc | 1 | $33 |
| Astellas Pharma US Inc | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: Ozempic, REXULTI, WATCHMAN FLX, Fluad, Veozah, Rybelsus, JARDIANCE, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
